"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glucemia,
Terapia Combinada,
Diabetes Mellitus Tipo 1,
Diabetes Mellitus Tipo 2,
Dieta para Diabéticos,
Monitoreo de Drogas,
Endocrinología,
Hiperglucemia,
Hipoglucemia,
Insulina/uso terapéutico,
Sistemas de Infusión de Insulina,
Monitoreo Ambulatorio,
Educación del Paciente como Asunto,
Medicina de Precisión,
Diabetes Mellitus Tipo 1/tratamiento farmacológico,
Diabetes Mellitus Tipo 2/tratamiento farmacológico,
Diabetes Mellitus Tipo 1/terapia,
Diabetes Mellitus Tipo 2/terapia,
Hipoglucemiantes/uso terapéutico,
Hipoglucemiantes/efectos adversos,
Insulina/efectos adversos
Turck, D;
Braegger, CP;
Colombo, C;
Declercq, D;
Morton, A;
Pancheva, R;
Robberecht, E;
Stern, M;
Strandvik, B;
Wolfe, S;
Schneider, SM;
Wilschanski, M.
"BACKGROUND:
Malnutrition is both a frequent feature and a comorbidity of cystic fibrosis (CF), with nutritional status strongly associated with pulmonary function and survival. Nutritional management is therefore standard of care in CF patients. ESPEN, ESPGHAN and ECFS recommended guidelines to cover nu...
Terapia Combinada,
Consenso,
Fibrosis Quística,
Suplementos Dietéticos,
Progresión de la Enfermedad,
Fibrosis Quística/terapia,
Dieta Saludable,
Síndromes de Malabsorción,
Desnutrición,
Apoyo Nutricional,
Desnutrición/prevención & control,
Medicina de Precisión,
Fibrosis Quística/dietoterapia
Werner, R. N;
Stockfleth, E;
Connolly, S. M;
Correia, O;
Erdmann, R;
Foley, P;
Gupta, A. K;
Jacobs, A;
Kerl, H;
Lim, H. W;
Martin, G;
Paquet, M;
Pariser, D. M;
Rosumeck, S;
Röwert-Huber, H. J;
Sahota, A;
Sangueza, O. P;
Shumack, S;
Sporbeck, B;
Swanson, N. A;
Torezan, L;
Nast, A.
BACKGROUND: Actinic keratosis (AK) is a frequent health condition attributable to chronic exposure to ultraviolet radiation. Several treatment options are available and evidence based guidelines are missing. OBJECTIVES: The goal of these evidence- and consensus-based guidelines was the development of tre...
In 2015 WHO updated the mhGAP guidelines, first issued in 2009, for the management of mental, neurological and substance use (MNS) disorders. In order to reduce the gap and to enhance the capacity of Member States to respond to the growing challenge, the World Health Organization (WHO) developed the Ment...
OBJECTIVE: The aim was to formulate clinical practice guidelines for acromegaly. PARTICIPANTS: The Task Force included a chair selected by the Endocrine Society Clinical Guidelines Subcommittee (CGS), five experts in the field, and a methodologist. The authors received no corporate funding or remuneratio...
"OBJECTIVE:
The aim was to formulate clinical practice guidelines for pheochromocytoma and paraganglioma (PPGL).
PARTICIPANTS:
The Task Force included a chair selected by the Endocrine Society Clinical Guidelines Subcommittee (CGS), seven experts in the field, and a methodologist. The authors received n...
Neoplasias de las Glándulas Suprarrenales,
Adrenalectomía,
Terapia Combinada,
Diagnóstico por Imagen,
Técnicas de Diagnóstico Endocrino,
Endocrinología,
Paraganglioma,
Atención Perioperativa/métodos,
Feocromocitoma,
Medicina de Precisión,
Feocromocitoma/terapia,
Neoplasias de las Glándulas Suprarrenales/terapia,
Paraganglioma/diagnóstico
